financetom
Business
financetom
/
Business
/
Form 8.3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3
Nov 4, 2025 7:57 AM

LONDON--(BUSINESS WIRE)--

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Millennium International Management LP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

American Axle & Manufacturing Holdings, Inc.

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

3rd November 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

Yes, Dowlais Group plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

USD 0.01 common (US0240611030)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

2,301,647

 

1.940%

 

393,318

 

0.331%

(2) Cash-settled derivatives:

 

 

-

 

-

 

4,331,827

 

3.650%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

 

-

TOTAL:

 

2,301,647

 

1.940%

 

4,725,145

 

3.982%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

US0240611030

Purchase

933

6.26

US0240611030

Purchase

645

6.37

US0240611030

Sale

4,000

6.37

US0240611030

Purchase

202

6.32

US0240611030

Sale

397

6.32

US0240611030

Sale

5,180

6.33

US0240611030

Purchase

5,513

6.23

US0240611030

Purchase

690

6.24

US0240611030

Purchase

24

6.34

US0240611030

Sale

14,937

6.34

US0240611030

Purchase

232

6.29

US0240611030

Purchase

122

6.35

US0240611030

Sale

3,638

6.35

US0240611030

Purchase

90

6.31

US0240611030

Sale

1,945

6.31

US0240611030

Purchase

670

6.30

US0240611030

Sale

2,000

6.30

US0240611030

Purchase

100

6.28

US0240611030

Purchase

105

6.22

US0240611030

Purchase

179

6.25

US0240611030

Sale

2,000

6.25

US0240611030

Sale

89

6.26

US0240611030

Purchase

68,437

6.37

US0240611030

Purchase

2

6.32

US0240611030

Sale

327

6.18

US0240611030

Sale

1,515

6.16

US0240611030

Sale

5

6.33

US0240611030

Sale

41

6.17

US0240611030

Sale

367

6.23

US0240611030

Sale

224

6.20

US0240611030

Sale

10

6.15

US0240611030

Sale

125

6.21

US0240611030

Purchase

11

6.34

US0240611030

Purchase

1

6.31

US0240611030

Sale

17,788

6.31

US0240611030

Sale

52

6.19

US0240611030

Sale

11

6.28

US0240611030

Sale

60

6.22

US0240611030

Purchase

403

6.26

US0240611030

Purchase

20,427

6.37

US0240611030

Purchase

31,015

6.32

US0240611030

Purchase

310

6.18

US0240611030

Purchase

400

6.16

US0240611030

Purchase

12,250

6.33

US0240611030

Purchase

400

6.17

US0240611030

Purchase

37,325

6.23

US0240611030

Purchase

1,972

6.20

US0240611030

Purchase

108

6.15

US0240611030

Purchase

11,183

6.24

US0240611030

Purchase

7,083

6.21

US0240611030

Purchase

5,977

6.34

US0240611030

Purchase

28

6.29

US0240611030

Purchase

6,320

6.35

US0240611030

Purchase

34,103

6.31

US0240611030

Sale

15,823

6.31

US0240611030

Purchase

920

6.30

US0240611030

Purchase

350

6.27

US0240611030

Purchase

16,213

6.19

US0240611030

Purchase

5,022

6.22

US0240611030

Purchase

179

6.12

US0240611030

Purchase

200

6.14

US0240611030

Sale

80

6.26

US0240611030

Purchase

6,426

6.37

US0240611030

Sale

4,126

6.37

US0240611030

Purchase

9,287

6.32

US0240611030

Sale

1,621

6.32

US0240611030

Purchase

1,506

6.33

US0240611030

Sale

10

6.33

US0240611030

Sale

93

6.17

US0240611030

Purchase

367

6.23

US0240611030

Sale

622

6.23

US0240611030

Sale

1,560

6.20

US0240611030

Sale

827

6.24

US0240611030

Sale

54

6.21

US0240611030

Purchase

2,800

6.34

US0240611030

Purchase

4

6.29

US0240611030

Purchase

3,092

6.35

US0240611030

Purchase

4,301

6.31

US0240611030

Sale

4,201

6.31

US0240611030

Purchase

300

6.30

US0240611030

Sale

5,822

6.19

US0240611030

Sale

306

6.28

US0240611030

Sale

91

6.22

US0240611030

Purchase

107

6.25

US0240611030

Sale

64

6.25

US0240611030

Sale

5

6.26

US0240611030

Purchase

1,171

6.32

US0240611030

Sale

6

6.32

US0240611030

Sale

153

6.18

US0240611030

Sale

3

6.16

US0240611030

Purchase

1,180

6.33

US0240611030

Sale

236

6.20

US0240611030

Purchase

947

6.34

US0240611030

Purchase

409

6.35

US0240611030

Purchase

10,192

6.31

US0240611030

Sale

10,092

6.31

US0240611030

Purchase

2,300

6.30

US0240611030

Sale

10,200

6.19

US0240611030

Purchase

1,200

6.25

US0240611030

Sale

200

6.14

US0240611030

Sale

8

6.26

US0240611030

Sale

874

6.33

US0240611030

Purchase

1,260

6.20

US0240611030

Purchase

38

6.21

US0240611030

Sale

1,559

6.34

US0240611030

Sale

703

6.29

US0240611030

Sale

570

6.35

US0240611030

Sale

133

6.31

US0240611030

Sale

1,170

6.27

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(c) Attachments

Class of relevant security:

 

USD 0.01 common (US0240611030)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

2,301,647

 

1.940%

 

393,318

 

0.331%

(2) Cash-settled derivatives:

 

 

-

 

-

 

4,331,827

 

3.650%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

 

-

TOTAL:

 

2,301,647

 

1.940%

 

4,725,145

 

3.982%

0

Class of relevant security:

 

USD 0.01 common (US0240611030)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

2,301,647

 

1.940%

 

393,318

 

0.331%

(2) Cash-settled derivatives:

 

 

-

 

-

 

4,331,827

 

3.650%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

 

-

TOTAL:

 

2,301,647

 

1.940%

 

4,725,145

 

3.982%

1

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Source: Millennium Partners, L.P.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TABLE-Mexico's Pemex sets December Maya price for international buyers
TABLE-Mexico's Pemex sets December Maya price for international buyers
Nov 14, 2025
MEXICO CITY, Nov 14 - Mexican state oil company Pemex revised its December term pricing formulas for crude shipped to customers in the Americas, Europe and Asia, the company's trading arm said on Friday. The following table lists adjustments to price constants for Pemex's flagship Maya heavy crude oil, as well as its Zapoteco, Istmo and Olmeca grades marketed to...
Medical device firm Retractable's Q3 sales dip
Medical device firm Retractable's Q3 sales dip
Nov 14, 2025
Overview * Retractable Technologies Q3 2025 sales slightly declined to $10.1 mln from $10.3 mln last year * Operating loss for Q3 2025 reduced to $3.7 mln from $5.1 mln last year * Company reports Q3 net income of $371 thousand, aided by $2.4 mln unrealized gains Outlook * Tariffs expected to continue impacting costs in future periods * Uncertainty...
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck
Nov 14, 2025
ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today congratulated its former client, Cidara Therapeutics, on its acquisition by Merck for approximately $9.2 billion. RedChip began introducing Cidara to its global microcap and small-cap investor network in 2021, when the company's market...
France finds Wish, Temu, AliExpress, eBay, Joom, Amazon broke rules on illicit products
France finds Wish, Temu, AliExpress, eBay, Joom, Amazon broke rules on illicit products
Nov 14, 2025
PARIS, Nov 14 (Reuters) - A French consumer watchdog found that besides Chinese fast-fashion retailer Shein, five other online platforms sold illicit products in France, a spokesperson for Commerce Minister Serge Papin said on Friday. The watchdog, called DGCCRF, said AliExpress and Joom were selling child-like sex dolls, while weapons such as brass knuckles and machetes were available on Wish,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved